Keyphrases
Neuroblastoma
75%
High-risk Neuroblastoma
49%
TIGIT
28%
Nectin-2
28%
Single-cell RNA Sequencing (scRNA-seq)
28%
Integrative Analysis
28%
Working Diagnosis
23%
Tumor
21%
Anti-GD2
19%
Interleukin-2
17%
Tumor Regression Rate
14%
Rate Factor
14%
Stage 4S
14%
Ganglioneuroblastoma
14%
Chronic Course
14%
Bone Metastasis
14%
Neuroblastoma Cancer
14%
Cancer Cells
14%
Regulatory Immune Response
14%
Netherlands
14%
Increased Incidence
14%
Late Events
14%
Patient Cohort
14%
Risk Factors
14%
Progressive Disease
14%
Disease Course
14%
Immune Monitoring
14%
Event-free Survival
14%
Improved Survival
14%
Immunomodulatory
14%
Complete Response
14%
Natural Killer Cells
12%
Granulocyte Colony-stimulating Factor (G-CSF)
11%
Catecholamines
10%
Clinical Course
10%
Immunotherapeutics
9%
T Cells
9%
High-dose Chemotherapy
7%
Liver Size
7%
Tumor Regression
7%
123I-MIBG
7%
Maintenance Therapy
7%
Dutch
7%
Primary Tumor
7%
Average Annual Percentage Change
7%
Anti-GD2 Antibody
7%
Isotretinoin
7%
Pediatric Patients
7%
Treatment Options
7%
NKT Cells
7%
Medicine and Dentistry
Ganglioneuroblastoma
100%
Immunotherapy
46%
RNA Sequence
28%
Disease
22%
Neoplasm
20%
Messenger RNA
17%
Tumor Regression
14%
Bone Metastasis
14%
Progressive Disease
14%
Diseases
14%
Solid Malignant Neoplasm
14%
Neuroblastoma Cell Line
14%
Pediatrics
14%
Drug Sensitivity
14%
Personalized Medicine
14%
Liquid Biopsy
14%
Transcriptomics
14%
Organoid
14%
Programmed Death-Ligand 1
11%
T Cell
11%
High Throughput Screening
10%
Event Free Survival
9%
Disease Course
9%
Clinical Decision Making
8%
Pediatrics Patient
7%
Primary Tumor
7%
Catecholamine Excretion
7%
Catecholamine
7%
Tumor
6%
Chemotherapy
5%
Immunosuppressive Drug
5%
Natural Killer Cell
5%
Cytotoxicity
5%
Survival Rate
5%
B Cell
5%
Natural Killer Cell
5%
Urinary System
5%
Treatment Response
5%
Prognostication
5%
Rhabdomyosarcoma
5%
Immunology and Microbiology
Immunotherapy
56%
RNA Sequence
28%
Programmed Death-Ligand 1
18%
Liver Size
14%
Stem Cell
14%
Drug Megadose
14%
Event Free Survival
9%
B Cell
9%
Natural Killer T Cell
9%
T Cell
9%
Myeloid
9%
Syngenic
9%
Natural Killer Cell
9%
Cytotoxicity
9%
Immunosuppressive Drug
9%
Survival Rate
9%
Catecholamine Excretion
7%
Catecholamine Urine Level
7%
Overall Survival
7%